Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2

Journal Article · · J. Med. Chem.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1900712
Journal Information:
J. Med. Chem., Vol. 64, Issue (15)
Country of Publication:
United States
Language:
ENGLISH

References (67)

Ca 2+ /CaM-D EPENDENT K INASES : From Activation to Function April 2001
Calmodulin-binding proteins: A journey of 40 years November 2018
Calcium Signaling December 2007
Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology September 2012
Components of a Calmodulin-dependent Protein Kinase Cascade November 1998
Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase July 2005
A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression July 2012
The camKK2/camKIV relay is an essential regulator of hepatic cancer May 2015
CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas March 2016
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis: AR coordinates anabolic program in prostate cancer May 2011
Calcium/Calmodulin-Dependent Kinase I and Calcium/Calmodulin-Dependent Kinase Kinase Participate in the Control of Cell Cycle Progression in MCF-7 Human Breast Cancer Cells June 2005
Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer: Repression of CAMKK2 Induces Androgen-Hypersensitivity May 2012
Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma February 2015
Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway December 1998
Protein kinase A negatively regulates VEGF-induced AMPK activation by phosphorylating CaMKK2 at serine 495 September 2020
Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells August 2017
ERK activation and cell growth require CaM kinases in MCF-7 breast cancer cells September 2009
CaM Kinase Kinase β-Mediated Activation of the Growth Regulatory Kinase AMPK Is Required for Androgen-Dependent Migration of Prostate Cancer Cells January 2011
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer November 2014
GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling April 2018
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma May 2011
Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: Our case series and literature review January 2010
Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD September 2017
An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model June 2018
Hypothalamic CaMKK2 Contributes to the Regulation of Energy Balance May 2008
CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins November 2020
Inhibition of Ca 2+ /Calmodulin-Dependent Protein Kinase Kinase 2 Stimulates Osteoblast Formation and Inhibits Osteoclast Differentiation: CAMKK2 REGULATES BONE REMODELING June 2013
Inhibition of CaMKK2 reverses age-associated decline in bone mass June 2015
The Ca 2+ /Calmodulin-Dependent Protein Kinase Kinase, CaMKK2, Inhibits Preadipocyte Differentiation October 2011
CAMKs support development of acute myeloid leukemia February 2018
In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds January 2020
CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression October 2014
G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis April 2016
Protein kinase CK2 in mammary gland tumorigenesis May 2001
Activation of the Aryl Hydrocarbon Receptor by the Calcium/Calmodulin-Dependent Protein Kinase Kinase Inhibitor 7-Oxo-7 H -benzimidazo[2,1- a ]benz[de]isoquinoline-3-carboxylic Acid (STO-609) August 2008
1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors May 2018
Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery August 2008
Toward a Pharmacophore for Kinase Frequent Hitters October 2004
Kinase hinge binding scaffolds and their hydrogen bond patterns October 2015
7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors January 2018
Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters November 1995
Synthesis and Reactivity of 7-Azaindoles (1H-Pyrrolo(2,3-b)pyridine) May 2001
Furopyridines. VI. Preparation and reactions of 2- and 3-substituted furo[2,3- b ]pyridines September 1986
Trifluoromethyl triflate: synthesis and reactions. September 1987
Structural Analysis of Inhibitor Binding to CAMKK1 Identifies Features Necessary for Design of Specific Inhibitors October 2018
Comprehensive analysis of kinase inhibitor selectivity October 2011
Binding and structural analyses of potent inhibitors of the human Ca2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors November 2019
Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening March 2004
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design March 2015
Intermolecular Sulfur···Oxygen Interactions: Theoretical and Statistical Investigations September 2015
A Single Amino Acid Difference between α and β Ca2+/Calmodulin-dependent Protein Kinase Kinase Dictates Sensitivity to the Specific Inhibitor, STO-609 March 2003
High throughput solubility measurement in drug discovery and development July 2007
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity August 2010
Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified? March 2018
The role of ligand efficiency metrics in drug discovery January 2014
Optimizing solubility: Kinetic versus thermodynamic solubility temptations and risks October 2012
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement February 2018
Characterization of the CaMKKβ–AMPK signaling complex December 2011
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability September 2007
Functional analysis of an R311C variant of Ca 2+ ‐calmodulin‐dependent protein kinase kinase‐2 (CaMKK2) found as a de novo mutation in a patient with bipolar disorder April 2020
Novel buffer systems for macromolecular crystallization February 2004
XDS January 2010
Overview of the CCP 4 suite and current developments March 2011
Phaser crystallographic software July 2007
REFMAC 5 for the refinement of macromolecular crystal structures March 2011
Features and development of Coot March 2010
MolProbity : all-atom structure validation for macromolecular crystallography December 2009